Skip to content
Drug recall · FDA · Published August 23, 2023

Contract Pharmaceuticals Limited Canada recalls Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals

Contract Pharmaceuticals recalls 1% Clindamycin Phosphate Topical Solution 60mL bottles due to slow leakage under the cap. Rx only product with specific lot number and expiration date.

🇺🇸 FDA recall #D-1139-2023DrugContract Pharmaceuticals ›
Take action

Contact the company & request your remedy

Recalling firmContract Pharmaceuticals Limited Canada7600 East Danbro Cres, N/A · Mississauga, N/A N/A
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Contract Pharmaceuticals is recalling 1% Clindam: 60mL topical solution bottles that may leak slowly under the cap. This could lead to medication contamination or improper use if the bottle is not properly sealed. Read more at govinfonow.com/recall/33167-clindamycin-topical-solution-recall-slow-leakage-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33167-clindamycin-topical-solution-recall-slow-leakage-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-1139-2023

Cite this page

“Clindamycin Topical Solution Recall: Slow Leakage Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33167-clindamycin-topical-solution-recall-slow-leakage-risk. Based on FDA recall #D-1139-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1139-2023%22&limit=1).

Why it’s dangerous

The container may leak slowly under the cap, which could lead to medication contamination or improper use. This might happen if the bottle is not properly sealed or if the cap is damaged.

Who’s affected

Prescription patients who have received this specific Clindamycin topical solution bottle. Those with sensitive skin or who use the product frequently may be at slightly higher risk due to potential contamination.

How to tell if you have this one

Check for the 1% Clindamycin Phosphate Topical Solution USP, 60mL bottle with NDC# 71428-003-60. The product was manufactured for Glasshouse Pharmaceuticals in Mississauga, Ontario, Canada, with lot # 118920 and expires January 2024.

  • Brand
    Contract Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC number 71428-003-60 and lot number 118920 on the bottle label.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product is safe for use if the container is properly sealed and the cap is intact. However, slow leakage could lead to contamination, so it's recommended to check for leaks before use.

How do I know if I have the recalled product?

Check for the NDC number 71428-003-60 and lot number 118920 on the bottle label. The product was manufactured in Mississauga, Ontario, Canada, and expires January 2024.

What should I do if I have this product?

The recall record does not specify a remedy, so you should check the product for leaks and contact your healthcare provider if you have concerns.

Take action

Contact Contract Pharmaceuticals

We’ve drafted a message you can send Contract Pharmaceuticals to request your refund or repair — edit it as you like.

Subject: Recall D-1139-2023 — Contract Pharmaceuticals Contract Pharmaceuticals

Hello,

I own a Contract Pharmaceuticals that is covered by recall D-1139-2023 from Contract Pharmaceuticals.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1139-2023 (August 23, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1139-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA